INTRODUCTION
Voltage-gated calcium channels (VGCCs) in animals sense a membrane potential change and drive a transient and rapid increase in cytosolic free Ca 2+ concentrations (Catterall, 2000) . VGCCs are composed of the poreforming subunit a 1 and auxiliary subunits a 2 /d, b and c, which play prominent roles in the regulation of traffic, expression and function of the a 1 subunit (Catterall et al., 2005; Jarvis & Zamponi, 2007) . The yeast Saccharomyces cerevisiae, a eukaryotic model organism, has only one homologue of the a 1 subunit, Cch1 (Paidhungat & Garrett, 1997; Fischer et al., 1997) . Like the animal a 1 subunit, Cch1 contains four structurally similar domains (I-IV), each of which has six transmembrane segments (S1-S6) (Fig. 1) . However, the positively charged residues conserved in the voltage-sensing S4 segments of the animal homologue a 1 subunit are poorly conserved in Cch1 (Paidhungat & Garrett, 1997 ), suggesting that Cch1 may be sensitive to an unusual voltage range or other stimuli.
To become functional, Cch1 needs another plasma membrane protein, Mid1, homologues of which are exclusively conserved in the fungus kingdom. Mid1 was first identified by screening of mutants that showed a mating pheromone-induced death (mid) phenotype because of a defect in Ca 2+ influx (Iida et al., 1994) . Although Mid1 has no homology in its amino acid sequence to any animal VGCC subunits, a recent report has suggested that it may resemble the animal a 2 /d subunit because of structural features, such as N-glycosylation, a cysteine-rich domain and a putative N-terminal signal peptide (Martin et al., 2011) . Deletion of either CCH1, MID1 or both results in quantitatively identical decreases in cell viability and Ca 2+ influx following exposure to mating pheromone (Paidhungat & Garrett, 1997; Fischer et al., 1997) , suggesting that Cch1 and Mid1 cooperate in the same process. This suggestion has been further supported by the finding that overexpression of both Cch1 and Mid1, but not single overexpression of either one of them, is effective in increasing Ca 2+ influx activity (Iida et al., 2004) . Muller et al. (2001) postulated that Cch1 and Mid1 constitute a high-affinity Ca 2+ influx system that becomes functional when cells are incubated in low-Ca 2+ media. Recently, Ecm7, a member of the PMP-22/EMP/ MP20/Claudin superfamily including c subunits of VGCC, was also suggested to be another subunit of the highaffinity Ca 2+ influx system (Martin et al., 2011) .
Cumulative works on Cch1 and Mid1 have revealed that Cch1/ Mid1 can be activated by several stimuli other than mating pheromone. These include store-operated stress (Locke et al., 2000) , endoplasmic reticulum (ER) stress (Bonilla & Cunningham, 2003) , hyperosmotic stress (Matsumoto et al., 2002) , alkaline stress (Viladevall et al., 2004) , cold stress (Peiter et al., 2005) , oxidative stress (Popa et al., 2010) and ethanol stress (Courchesne et al., 2011) .
The activity of Cch1 is suggested to be important for the activation of calcineurin, a Ca 2+ /calmodulin-dependent serine/threonine protein phosphatase, which is necessary for cellular responses to various stimuli (Bonilla et al., 2002; Miyakawa & Mizunuma, 2007; Stie & Fox, 2008) .
Interestingly, activated calcineurin appears to dephosphorylate Cch1, thereby inducing the feedback-inhibition of Ca 2+ influx in response to mating pheromone and ER stress (Bonilla & Cunningham, 2003) . Also, the mitogen-activated protein (MAP) kinase Mpk1 and its upstream regulator Bck1 are specifically required for the activation of Cch1 during ER stress (Bonilla & Cunningham, 2003) . Some unknown targets of transcription factor Ste2, which is activated by the MAP kinase Fus3, are necessary for Cch1 activation in response to mating pheromone (Muller et al., 2001) . However, the molecular mechanisms underlying the regulation of Cch1 remain elusive. In addition, the structurefunction relationship of Cch1 has not yet been investigated.
Here, to investigate the structure-function relationship, we identified two mutant alleles of CCH1, CCH1* (or CCH1-star, resulting in a higher Ca 2+ uptake activity of the gene product) and cch1-2, formerly designated mid3-2 (Iida et al., 1994) . We found that the product of the CCH1* allele had four mutations, one of which (N1066D) accounted for its increased activity. The Asn 1066 residue is located in the cytoplasmic loop between domains II and III. This is the first report about a hyperactive mutation in Cch1. The cch1-2 allele was found to have the P1228L mutation, which leads to a partial loss in Cch1 function. Pro 1228 is conserved completely from fungi to humans and is located in the extracellular S1-S2 linker of domain III. We discuss the importance of the structural regions containing the two mutations.
METHODS
Yeast stains, plasmids and media. The wild-type strain H207 (MATa his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2) and its derivative mutant strains H3032 [MATa cch1-2 (formerly mid3-2) his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2], H317 (MATa cch1D : : HIS3 his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2), H319 (MATa mid1D5 : : HIS3 cch1D : : HIS3 CNB1 his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2), H321 (MATa MID1 CCH cnb1D : : HIS3 his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2) and H345 (MATa mid1D5 : : HIS3 cch1D : : TRP1 cnb1D : : HIS3 his3-D1 leu2-3,112 trp1-289 ura3-52 sst1-2) were used in this study.
The low-copy plasmids YCplac33, pBC111, pBCS-CCH1 and pBCT-CCH1 used in this study were described previously (Iida et al., 2007; Teng et al., 2008) . Note that the wild-type CCH1 gene has been derived from yeast strain H207 and is expressed from its own promoter on pBCS-CCH1 and a strong TDH3 promoter on pBCT-CCH1. In our previous paper (Iida et al., 2007) , we added the suffix 'H' to the H207derived CCH1 gene, as in CCH1H, because we needed to use this suffix to distinguish between H207-and X2180-1A-derived CCH1 genes. In this paper, however, we did not add this suffix because we only used the H207-derived CCH1 gene. The low-copy plasmid YCpS-MID1 (ARS1 CEN4 URA3 MID1p-MID1-ADH1t) contains the MID1 gene, expression of which is under the control of its own promoter.
Synthetic media SD and SD.Ca100 medium were prepared as described previously (Iida et al., 1994) . SD.Ca100 contains 100 mM CaCl 2 and SD medium 681 mM CaCl 2 .
DNA sequencing and plasmid construction. The cch1-2 (or mid3-2) gene of H3032 was amplified by PCR and was directly sequenced with the BigDye Terminator version 3.1 cycle sequencing kit (Applied Biosystems), as described previously (Iida et al., 2007) . and N1330S, open circles) in CCH1* and the P1228L mutation in cch1-2 (closed circle) are shown. Roman numerals I-IV represent putative domains and Arabic numerals 1-6 represent putative transmembrane segments (S1-S6). P represents the putative pore loop. Putative S4 segments in domains I-III, containing repeated motifs of a positively charged residue followed by two hydrophobic residues, are shown with dark grey boxes. The putative S4 segment of domain IV lacks this motif. Other putative transmembrane segments are shown with light grey boxes. Amino-and carboxyl-termini are located in the cytoplasm.
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In vitro site-directed mutagenesis. In vitro site-directed mutagenesis was performed using the QuikChange Site-directed Mutagenesis kit (Stratagene). Plasmids containing mutant CCH1 genes were as follows: pBCS-CCH1V49A, pBCS-CCH1N1066, pBCS-CCH1T1145H, pBCS-CCH1N1330S, pBCS-CCH1N1066Q, pBCS-CCH1N1066H, pBCS-CCH1N1066K and pBCS-CCH1N1066E. PCR primers used here are listed in Table 1 .
Determination of cell viability. The viability of cells exposed to 6 mM a-factor in SD.Ca100 medium was determined by the methylene blue liquid method (Iida et al., 1990 (Iida et al., , 1994 .
Determination of Ca 2+ accumulation in yeast cells. Exponentially growing cells in SD.Ca100 medium were incubated for 2 h with 45 CaCl 2 (185 kBq ml 21 ; 1.85 kBq nmol 21 ; PerkinElmer) in the presence or absence of 6 mM a-factor. Samples were taken, filtered through Millipore filters (type-HA; 0.45 mm) that had been presoaked in 5 mM CaCl 2 , and washed five times with the same solution. The radioactivity retained on the filters was counted with a scintillation mixture, ReadyProtein (Beckman Japan), in a liquid scintillation counter.
Western blotting and fluorescence microscopy. Western blotting was carried out according to Iida et al. (1994) except that samples for SDS-PAGE were denatured for 15 min at 37 uC. Affinity-purified rabbit polyclonal antibodies against the Cch1 carboxyl-terminal peptide spanning from amino acid residue 1949 to 2039 described previously (Iida et al., 2007) were used at a concentration of 0.07 mg ml 21 to detect wild-type and various mutant forms of the Cch1 protein. Fluorescence microscopy on cells expressing Cch1-P1228L-EGFP and Cch1-EGFP was performed as described previously (Tada et al., 2003) .
Statistical analysis. Significance was determined using the unpaired Student's t test with a P-value ,0.05 required for significance.
RESULTS

CCH1* is a hyperactive mutant
When we cloned the CCH1 gene by PCR with LA Taq DNA polymerase with a relatively low fidelity, we acquired a mutant gene whose product had an increased Ca 2+ uptake activity, and named it CCH1*. When exposed to the mating pheromone a-factor, cch1-defective mutants die because of a deficiency in Ca 2+ uptake. This conditionally lethal phenotype and the low Ca 2+ uptake ability were used to assess the activity of wild-type and mutant Cch1 proteins in this study. To characterize Cch1*, low-copy plasmids containing CCH1* or wild-type CCH1, expression of which was under the control of the CCH1 promoter, were introduced into cch1D cells, and the resulting transformants, designated CCH1* cells and CCH1 cells hereafter, respectively, were subjected to 45 Ca 2+ accumulation assays. Cells were incubated to the exponential phase in SD.Ca100 medium and then incubated for a further 2 h with 6 mM a-factor, a Cch1 stimulator. Results showed that CCH1 cells displayed the same Ca 2+ uptake activity as cells expressing wild-type Cch1 from its chromosomal locus, designated WT cells hereafter [66±3.5 pmol (10 6 cells) -1 for CCH1 cells, 66±15 pmol (10 6 cells) -1 for WT cells] ( Fig. 2a ). Under the same conditions, CCH1* cells exhibited a significant increase in Ca 2+ accumulation activity [108±12 pmol (10 6 cells) -1 ] (Fig. 2a ). The amounts of Cch1* and wildtype Cch1 proteins in the respective transformants were almost the same, but were slightly lower than that of the wild-type Cch1 protein produced from its chromosomal locus, as revealed by Western blotting (Fig. 2b ). Therefore, CCH1* is a hyperactive mutant. DNA sequencing of the mutant gene showed that it contained four amino acid substitutions, V49A, N1066D, Y1145H and N1330S ( Fig. 1 ).
Cch1 has basal Ca 2+ influx activity under non-stimulating conditions, and is activated by a variety of stimuli, including a-factor (Fischer et al., 1997; Muller et al., 2001; Paidhungat & Garrett, 1997) . Therefore, we examined the Ca 2+ influx activity of Cch1* under non-stimulating conditions. Fig.  2 (a) shows that Ca 2+ accumulation in CCH1* cells was higher than that in CCH1 cells and WT cells [57±12 for CCH1*, 16±1 for CCH1 and 15±4 for WT, in pmol (10 6 cells) -1 ]. This indicates that Cch1* undergoes a spontaneous increase in basal Ca 2+ influx activity. Note that the net increase of Ca 2+ influx activity in CCH1* cells, defined as the activity in the presence of a-factor minus the activity in the absence of it, was comparable to that in CCH1 cells ( Fig.  2a ). This suggests that the increased activity of CCH1* cells is not ascribed to a change in sensitivity to a-factor. To examine this suggestion further, we performed doseresponse experiments with this factor. Fig. 2 (c) shows that the Ca 2+ influx activities of CCH1 and CCH1* cells were increased roughly in parallel with the increase of the a-factor concentration we tested, supporting the above suggestion.
Increased activity of Cch1* depends on Mid1
As Cch1 functions with Mid1 to mediate Ca 2+ influx in afactor-stimulated cells (Fischer et al., 1997; Iida et al., 2004; Paidhungat & Garrett, 1997) , this raises the question of whether the increased activity of Cch1* still depends on Mid1. To address this, we introduced a plasmid containing CCH1* into mid1D cch1D cells to obtain transformants (designated mid1D CCH1* cells). We selected transformants producing the Cch1* protein whose amount was essentially the same as that of the Cch1 protein produced by WT cells (data not shown) and those selected were subjected to Ca 2+ uptake assays in the presence and absence of a-factor. As shown in Fig. 2(a) , when the MID1 gene is deleted, the higher activity of Cch1* decreased dramatically to a level comparable to that of cch1D cells in both the presence and the absence of a-factor [10±7 for mid1D CCH1* versus 17±1 for cch1D in the presence of afactor; 3±1 for mid1D CCH1* versus 3±1 for cch1D in the absence of a-factor; in pmol (10 6 cells) -1 ]. These results indicate that the higher activity of Cch1* is dependent on Mid1.
Cch1* maintains its susceptibility to regulation by calcineurin
As Cch1 activity is negatively regulated by calcineurin (Bonilla & Cunningham, 2003) , we presumed that the increased activity of Cch1* may be caused by loss or attenuation of negative regulation by calcineurin. To examine this possibility, we investigated the Ca 2+ uptake activity of cnb1D cch1D mid1D cells co-expressing CCH1* and MID1 (cnb1D CCH1*) and that of cnb1D cells carrying the respective empty vectors (cnb1D). Cnb1 is the regulatory subunit of calcineurin, and deletion of CNB1 results in a lack of calcineurin activity (Cyert & Thorner, 1992; Liu et al., 1991) . The amount of Cch1* produced from the CCH1 promoter in cnbD CCH1* cells was comparable to that of cnb1D cells (Fig. 3b ). Two hours after exposure to a-factor, Ca 2+ uptake activity in cnb1D cells was approximately sevenfold higher than that in WT cells (455±62 for cnb1D versus 66±15 for WT, pmol/10 6 cells) (Figs 2a, 3a) , as reported previously (Bonilla & Cunningham, 2003) . Ca 2+ uptake activity in cnb1D CCH1* cells was approximately eightfold higher than that in CCH1* cells [895±182 for cnb1D CCH1* versus 108±12 for CCH1*, in pmol (10 6 cells) -1 ]. In the absence of a-factor, Ca 2+ uptake activity in cnb1D cells was approximately sevenfold higher than that in WT cells [106±10 for cnb1D CCH1 versus 15±4 for WT, in pmol (10 6 cells) -1 ], and Ca 2+ uptake activity in cnb1D CCH1* cells was approximately sevenfold higher than that in CCH1* cells [417±67 for cnb1D CCH1* versus 57±12 for Enolase is a loading control. (c) Dose-response experiments with a-factor. Ca 2+ uptake activity of cells incubated for 2 h with appropriate concentrations of a-factor was measured as above.
The strains used were the same as those in (b). Data are the mean±SD of three independent experiments.
On: Thu, 27 Dec 2018 18:33:22 CCH1*, in pmol (10 6 cells) -1 ]. Note that deletion of CNB1 resulted in a similar increase ratio in Cch1* and Cch1. These results indicate that the increased Ca 2+ uptake activity of Cch1* is not due to the diminution of calcineurin regulation. In other words, mutations do not affect the susceptibility of Cch1 to regulation by calcineurin.
Negativity of substituted amino acids at Asp 1066 accounts for the increased activity of Cch1*
As Cch1* has four missense mutations as described above (Fig. 1) , we investigated which mutation(s) among these is responsible for its increased activity. We therefore constructed four kinds of cch1D mutant carrying each of the single mutations, V49A, N1066D, T1145H or N1330S, on a low-copy plasmid and mutants were examined for Ca 2+ uptake activity in the presence or absence of a-factor. As shown in Fig. 4(a) , only the N1066D mutation caused a significant increase in Ca 2+ uptake activity [118±11 for N1066D versus 66±15 for WT in the presence of a-factor; 44±9 for N1066D versus 15±4 for WT in the absence of a-factor; in pmol (10 6 cells) -1 ]. On the other hand, the Ca 2+ uptake activity of the other mutations was the same as that of the WT [73±12 for V49A, 68±2 for T1145H, 75±12 for N1330S versus 66±15 for WT in the presence of a-factor; 15±1 for V49A, 14±3 for T1145H, 16±2 for N1330S versus 15±4 for WT in the absence of a-factor; in pmol (10 6 cells) -1 ]. These results indicate that only the N1066D mutation is responsible for the increased activity of Cch1*.
To investigate what property of Asn is important for an increase in Cch1* activity, we substituted a variety of amino acids for Asn 1066 and examined the Ca 2+ accumulation activity of mutant proteins expressed in cch1D cells. As shown in Fig. 4(b) , similar to Asp, substitution of the negatively charged Glu for Asn 1066 resulted in a marked increase in the Ca 2+ accumulation activity of cells treated for 2 h with a-factor. In contrast, no effect on the Ca 2+ accumulation activity of cells was seen with substitution of an uncharged amino acid, Gln, a positively (but weakly) charged amino acid, His, and a positively charged amino acid, Lys, for Asn 1066 (Fig. 4b) . Therefore, we concluded that substitution of negatively charged amino acids for Asn 1066 leads to elevations in Cch1 activity.
Based on a conventional transmembrane domain prediction of ion channels (Jan & Jan, 1990) , Asn 1066 was predicted to be located in the large cytoplasmic loop connecting domains II and III. We compared the amino acid sequences of the loop connecting domain II and III of the VGCC family and found that the Asn residue is not conserved in the VGCCs family (data not shown).
The cch1-2 mutation has occurred at the highly conserved Pro 1228 of Cch1
We have shown that mid3 is allelic to cch1 (Iida et al., 2007) and that cells carrying the mid3-2 allele show phenotypes of mating pheromone-induced death (mid) and low Ca 2+ uptake (Iida et al., 1994) . DNA sequencing of the genomic DNA of this mutant (strain H3032) showed that mid3-2 has a missense mutation, causing a Pro 1228 to Leu substitution (P1228L). We therefore renamed mid3-2 as cch1-2. We reported previously that the mid3-1 (cch1-1) mutation causes a Gly 1265 to Glu substitution (Iida et al., 2007) .
Based on a conventional transmembrane domain prediction (Jan & Jan, 1990) , Pro 1228 was predicted to be located in the extracellular linker connecting S1 and S2 segments of domain III (Fig. 1) . To investigate the significance of this residue, we compared the amino acid sequences of the corresponding S1-S2 linkers of various VGCCs. As shown in Fig. 5 , the proline residue is highly conserved from yeasts to humans, suggesting that this residue is important for the function of VGCCs.
P1228L substitution results in a hypoactive mutation
To examine quantitatively the effect of the P1228L mutation on Cch1 function, a low-copy plasmid containing the cch1-2 Fig. 3 . Mutations in CCH1* do not affect regulation from calcineurin. (a) Ca 2+ uptake activity. Ca 2+ accumulation was measured as described in the legend to Fig. 2 . Data for WT and cch1D are the same as those presented in Fig. 2 but at a different scale. Other strains examined are as follows: cnb1D, strain H321 (cnb1D) transformed with two empty vectors YCplac33 and pBC111; cnb1D CCH1*, strain H345 (cnb1D mid1D cch1D) transformed with YCpS-MID1 and pBCS-CCH1*. Data are the mean±SD of at least three independent experiments. (b) Protein levels. The Cch1 protein was detected as described in the legend to allele driven under control of either the CCH1 promoter or the transcriptionally strong TDH3 promoter was constructed, and the resulting plasmids, designated P1228L and P1228Lox, respectively, in Fig. 6 were used to transform cch1D or WT cells. Transformants were then tested for viability and Ca 2+ uptake activity following exposure to afactor. The results showed that cch1D cells bearing P1228L had roughly half as much viability and Ca 2+ uptake activity as WT cells, while those bearing P1228Lox had only a slightly higher Ca 2+ uptake activity than those bearing P1228L. When P1228Lox was expressed in WT cells, viability and Ca 2+ uptake activity decreased by approximately 20 and 40 %, respectively. These results indicate that the P1228L substitution results in a hypoactive mutation and that this product has a partial dominant-negative effect on WT Cch1 when overexpressed.
P1228L substitution does not affect the amount and subcellular localization of the mutant protein
It is possible that the low activity of P1228L may be due to instability and/or mislocalization of the mutant protein. To examine these possibilities, we first checked the amount of mutant protein by Western blotting. As shown in Fig. 7(a) , the amount of P1228L protein produced from the P1228L plasmid was essentially the same as that of the WT protein.
In addition, the P1228Lox plasmid was found to produce approximately 25-fold more protein than the P1228L plasmid. Confocal fluorescence microscopic analysis of P1228L fused to green fluorescent protein (GFP) produced from the TDH3 promoter revealed that P1228L-GFP was localized at the plasma membrane and an ER-like organelle (Fig. 7b, bottom panels) . This distribution is very similar to that of WT Cch1 expressed from the same promoter (Fig.  7b , top panels; also see Iida et al., 2004 Iida et al., , 2007 . Therefore, we concluded that the amount and subcellular localization of P1228L are normal and its low Ca 2+ uptake activity is due to loss of activity.
DISCUSSION
In the present study, we characterized two cch1 alleles, CCH1* and cch1-2 (mid3-2). First, we have shown that Cch1*, containing four mutations (V49A, N1066D, T1145H and N1330S), exhibits a significantly higher Ca 2+ uptake activity than that in WT Cch1, not only in response to a-factor but also in the absence of any stimuli (Fig. 2) . CCH1* is thus a hyperactive mutation. Among the four mutations, only the N1066D mutation was found to be responsible for the increase in its activity (Fig. 4a ). In addition, substitution of various amino acids with different chemical and structural properties for Asn 1066 indicated that the negative charge of substituted amino acids such as Asp or Glu is responsible for the increase in Ca 2+ uptake activity (Fig. 4b) . These results suggest that Asn 1066 is important for the regulation of Cch1 activity. Our results have also shown that Cch1* activity is still dependent on Mid1 and undergoes regulation by calcineurin (Figs 2 and 3) .
In eukaryotic cells, Ca 2+ plays an important role in signal transduction as a second messenger (Catterall, 2000) . Therefore, Ca 2+ channels are tightly controlled and, in general, are usually closed. The open conformation is favoured only when a sensor receives its stimulus, such as a Fig. 4 . Substitution of negatively charged amino acid for Asn 1066 results in a significant increase in Ca 2+ uptake activity in Cch1. Ca 2+ accumulation was measured as described in the legend to Fig. 2. (a) The N1066D mutation is responsible for the increase in Cch1* activity. Data for WT, cch1D and CCH1* are the same as those presented in Fig. 2 . V49A, N1066D, T1145H and N1330S indicate strain H317 (cch1D) transformed with plasmids pBCS-CCH1V49A, pBCS-CCH1N1066D, pBCS-CCH1T1145H and pBCS-CCH1N1330S, respectively. (b) Effect of the substitution of various amino acids for Asn 1066 on Cch1 function. Data for WT, cch1D and CCH1* are the same as those presented in Fig. 2 . N1066D, N1066Q, N1066H, N1066K and N1066E indicate strain H317 (cch1D) transformed with plasmids pBCS-CCH1N1066Q, pBCS-CCH1N1066H, pBCS-CCH1N1066K and pBCS-CCH1N1066E, respectively. V, Val; A, Ala; N, Asn; D, Asp; T, Thr; H, His; S, Ser, Q, Gln; K, Lys; E, Glu. Data are the mean±SD of at least three independent experiments. # , P50.00005 (N1066D vs. WT, w/ a-factor); ## , P50.00003 (N1066D vs. WT, w/o a-factor); ###, P50.03328 (N1066E vs. WT, w/ a-factor).
ligand, voltage or stretch force. In this context, it is possible that the N1066D mutation of Cch1* biases the gate towards opening even without any stimuli.
Structurally related voltage-gated Ca 2+ , K + and Na + channels are in the closed state that is blocked on their intracellular side by an activation gate at a resting membrane potential (Bähring and Covarrubias, 2011) . In response to changes in the membrane potential, structural rearrangement of voltage sensor domains results in conformational changes in the channel (the open state), allowing ions to flux across the membrane. It has been shown that many mutations in ion channels disrupt their normal structure, thereby severely affecting channel opening and closing (Sunami et al., 2001) . Cch1, which is a member of the voltage-gated ion channel family, is no exception. It has been shown that replacement of Gly 1265 with any larger amino acid residue in the S2-S3 linker of domain III perturbs the spatial arrangement of S2 and S3, resulting in loss of activity of Cch1 (Iida et al., 2007) . It is possible that Asn 1066 is important for the maintenance of the Cch1 closed structure, and replacement of this residue with a negatively charged amino acid may change the conformation of the cytoplasmic II-III interdomain loop, thereby making the Cch1 structure easy to open even in the absence of stimuli.
Activation of a high-affinity Ca 2+ influx system (HACS) composed of Cch1 is regulated by calcineurin, the MAP kinase Mpk1 and its upstream regulator Bck1, and transcription factor Ste2 (Bonilla & Cunningham, 2003; Martin et al., 2011; Muller et al., 2001) . It has also been shown that there are many proteins that prevent spontaneous activation of HACS (Martin et al., 2011) . However, it is unknown how these factors regulate HACS, especially Cch1, and which sites in Cch1 are involved in interactions with those regulators. By contrast, the interaction sites of mammalian VGCC a 1 subunits are known to some extent. For example, the II-III interdomain loop of Ca v 2.1 and Ca v 2.2 subunits interacts with a number of synaptic proteins (Catterall, 2000; Spafford & Zamponi, 2003) . The II-III interdomain loop of Ca v 3.2 interacts with Gb2 subunits (Wolfe et al., 2003) and is a substrate for calmodulin-dependent protein kinase (Welsby et al., 2003) . Therefore, it is possible that the II-III loop in Cch1 is important for interactions with its regulators. The In this study, we have also shown that the P1228L mutation leads to a marked loss of activity in Cch1, and appears not to affect the stability and localization of the P1228L mutant protein because the amount and subcellular localization of P1228L are essentially the same as those of the WT Cch1 (Fig. 7) . The Pro 1228 residue is located in the extracellular S1-S2 linker of domain III and is well conserved from fungi to humans (Figs 1 and 5 ).
Activation of Cch1 requires Mid1 in response to many stimuli including a-factor. Mid1 is a putative analogue of the a 2 d subunit of animal VGCCs. Coexpression of the a 2 d subunit with the a 1 subunit has been shown to modify many properties of the a 1 subunit, including the acceleration of activation and inactivation kinetics (Wakamori et al., 1999) . It has been suggested that more than one extracellular loop of the a 1 subunit interacts with the a 2 d subunit, and domain III appears to interact strongly with the a 2 d subunit (Gurnett et al., 1997) . As Cch1 has been shown to be associated with Mid1 by in vivo co-immunoprecipitation (a) Viability of cells incubated with 6 mM a-factor for 8 h in SD.Ca100 medium. Strains examined are as follows (left to right): WT, strain H207 (CCH1) transformed with pBC111; cch1D, strain H317 (cch1D) transformed with pBC111; P1228L, strain H317 transformed with pBCS-CCH1P1228L; P1228Lox, strain H317 or H207 transformed with pBCT-CCH1P1228L; CCH1ox, strain H207 transformed with pBCT-CCH1. (b) Ca 2+ accumulation in cells during a 2 h incubation with 6 mM a-factor in SD.Ca100 medium. Yeast strains used were the same as those in (a). Data are the mean±SD of at least three independent experiments. # , P50.00016 (P1228L vs. WT, w/ a-factor); ## , P50.01111 (P1228L vs. P1228Lox in cch1D cells, w/ a-factor).
CCH1Hox-EGFP
P1228Lox-EGFP WT, strain H207 (CCH1) transformed with pBC111; P1228L and P1228Lox, strain H317 (cch1D) transformed with pBCS-CCH1P1228L and pBCT-CCH1P1228L, respectively. Wholecell extracts of the resulting transformants were subjected to Western blotting. Note that samples were appropriately diluted as indicated under the panel. (b) Subcellular localization of P1228L-EGFP. Cells growing exponentially in SD.Ca100 medium were observed by confocal fluorescence microscopy (left) or differential interference contrast microscopy (right). CCH1Hox-EGFP (top) and P1228Lox-EGFP (bottom), strain H317 (cch1D) transformed with pBCT-CCH1H-EGFP and pBCT-CCH1P1228L-EGFP, respectively. Essentially the same results were obtained in two additional experiments.
analysis (Locke et al., 2000) , it is possible that the domain III extracellular S1-S2 linker of Cch1 is an important interaction site for Mid1, and the P1228L mutation in this linker may interfere with this interaction, leading Cch1 to partially lose its function.
In summary, we have found two important sites that are vital for Cch1 function. This research extends the understanding of the structure-function relationship and regulation of Cch1.
